← SynDRA
ROSMARINIC ACID
SynDRA canonical compound SYN0004247 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | MCL1 | TYR |
|---|
| Mechanism of action | GABA transaminase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- GABA transaminase inhibitor
- TYR INHIBITOR
- MCL1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- AKR1B1
- ENPP1
- TTR
- SNCA
- HSD17B2
- FYN
- MMP1
- BLM
- PTGS1
- APP
- THRB
- TDP1
- STAT5B
- STAT3
- STAT1
- SRC
- ATAD5
- SLCO1B3
- SLCO1B1
- RECQL
- PTGS2
- POLB
- GAA
- PLA2G7
- PKM
- APEX1
- MAPT
- LCK
- KDM4E
- KDM1A
- JUN
- BAZ2B
- HSD17B1
- HDAC6
- GBA1
- USP2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- DPOLB
- G3P
- GNAI1
- IF4H
- MITF
- PABP1
- RGS12
- SAE1
- THB
- UBA2
Cross-references
Synonyms
- Rosemary acid
- (R)-rosmarinic acid
- UNII-MQE6XG29YI
- Rosmarinate
- MQE6XG29YI
- CHEMBL324842
- CHEBI:50371
- Labiatenic acid
- C18H16O8
- (R)-O-(3,4-Dihydroxycinnamoyl)-3-(3,4- dihydroxyphenyl)lactic acid
- 3,4-Dihydroxycinnamic acid (R)-1-carboxy-2-(3,4-dihydroxyphenyl)ethyl ester
- (2R)-3-(3,4-dihydroxyphenyl)-2-[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyloxy]propanoic acid
- Rosemaric acid
- (2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-propanoic acid
- Labiatic acid
- trans-Rosmarinic acid
- ORISTRACT ROA
- RM 21A
- NPLC 0542
- CHEBI:17226
- Acid, Rosemary
- Acid, Rosmarinic
- RefChem:6204
- DTXCID801326415
- Rosmarinicacid
- Rosmarinic acid racemate
- Rosmarimic acid
- Rosemarinic Acid
- MFCD00017740
- rosmaric acid
- CCRIS 9361
- HSDB 7688
- Rosmarinic acid CRS
- Rosmarinic acid, 2
- Rosmarinic acid, 96%
- bmse000648
- Rosmarinic acid (Standard)
- (R)-(+)-Rosmarinic Acid
Look up ROSMARINIC ACID in the interactive SynDRA portal →